scispace - formally typeset
Open AccessJournal ArticleDOI

Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds

Reads0
Chats0
TLDR
The coordination of anti-growth signaling and natural compound studies will provide insight into the future application of these compounds in the clinical setting.
About
This article is published in Seminars in Cancer Biology.The article was published on 2015-12-01 and is currently open access. It has received 96 citations till now. The article focuses on the topics: Hippo signaling pathway & Autocrine signalling.

read more

Citations
More filters
Journal ArticleDOI

Targeting apoptosis in cancer therapy

TL;DR: The main pathways that regulate apoptosis as well as other signalling pathways that interact with them are presented, highlighting actionable molecular targets for anticancer therapy and an overview of therapeutic agents exploiting apoptosis currently in clinical translation and known mechanisms of resistance to these agents are provided.
Journal ArticleDOI

Overcoming cancer therapeutic bottleneck by drug repurposing

TL;DR: This review presents various promising repurposed non-oncology drugs for clinical cancer management and classify these candidates into their proposed administration for either mono- or drug combination therapy.
Journal ArticleDOI

Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks.

TL;DR: Focus is set on the pressing need to include glycans and glycoconjugates in comprehensive panomics models envisaging molecular-based precision medicine capable of improving patient care and the transversal nature of glycans throughout the currently accepted cancer hallmarks.
Journal ArticleDOI

NF-κB pathways in the development and progression of colorectal cancer.

TL;DR: There is sufficient evidence gained from cell lines and animal models that NF-κB is involved in cancer-related processes, but because of a lack of studies in human tissue, clinical evidence of its importance is limited in patients with CRC.
Journal ArticleDOI

RAS-mediated oncogenic signaling pathways in human malignancies.

TL;DR: This review highlights the recent literature on how oncogenic RAS negatively use its signaling web in deregulating the expression and functioning of various effector molecules in the pathogenesis of human malignancies.
References
More filters
Journal ArticleDOI

Hallmarks of cancer: the next generation.

TL;DR: Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Journal ArticleDOI

Mutation and Cancer: Statistical Study of Retinoblastoma

TL;DR: The hypothesis is developed that retinoblastoma is a cancer caused by two mutational events, in the dominantly inherited form, one mutation is inherited via the germinal cells and the second occurs in somatic cells.
Journal ArticleDOI

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

TL;DR: In this article, an improved two-hybrid system was employed to isolate human genes encoding Cdk-interacting proteins (Cips) and found that CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2.
Journal ArticleDOI

Integrated genomic characterization of endometrial carcinoma

Gad Getz, +283 more
- 02 May 2013 - 
TL;DR: In this paper, the authors performed an integrated genomic, transcriptomic and proteomic characterization of 373 endometrial carcinomas using array-and-sequencing-based technologies, and classified them into four categories: POLE ultramutated, microsatellite instability hypermutated, copy-number low, and copy number high.
Journal ArticleDOI

Comprehensive genomic characterization of squamous cell lung cancers

Peter S. Hammerman, +345 more
- 27 Sep 2012 - 
TL;DR: It is shown that the tumour type is characterized by complex genomic alterations, with a mean of 360 exonic mutations, 165 genomic rearrangements, and 323 segments of copy number alteration per tumour.
Related Papers (5)